Reduced expression of TGF β1RII in agnogenic myeloid metaplasia is not due to mutation or methylation

Leukemia Research

Volumn 30, Issue 1, 2006, Pages 47-53

  Hemavathy, Kirugaval C ^a   Chang, Tsong H ^a   Zhang, Haowei ^a   Charles, William ^a   Goldberg, Amit ^a   Aithal, Sramila ^a   Novetsky, Allan D ^a   Wang, Jen C ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

Agnogenic myeloid metaplasia (AMM); Methylation; Mutation; Myelofibrosis; TGF 1RII

Indexed keywords

CD34 ANTIGEN; HISTONE DEACETYLASE; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1 RECEPTOR II; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; MYELOID METAPLASIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

CELL PROLIFERATION; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; MALE; MEGAKARYOCYTES; MUTATION; MYELOFIBROSIS; MYELOID METAPLASIA; PROMOTER REGIONS (GENETICS); RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 27844577336     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2005.06.010     Document Type: Article

References (34)

1. M.C. Le Bousse-Kerdiles, and M.C. Martyre French INSERM research network on idiopathic myelofibrosis: involvement of the fibrogenic cytokines, TGF-beta and bFGF, in the pathogenesis of idiopathic myelofibrosis Pathol Biol (Paris) 49 2001 153 157
2. G. Barosi, G. Viarengo, and A. Pecci Diagnostic and clinical relevance of the number of circulating CD34(+) cells in myelofibrosis with myeloid metaplasia Blood 98 2001 3249 3255
3. J. Hatzfeld, M.L. Li, and E.L. Brown Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta1 or Rb oligonucleotides J Exp Med 174 1991 925 929
4. J. Massague, S.W. Blain, and R.S. Lo TGF-β signaling in growth control, cancer and heritable disorders Cell 103 2000 295 309
5. M.C. Le Bousse-Kerdiles, S. Chevillard, and A. Charpentier Differential expression of transforming growth factor-β, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia Blood 88 1996 4534 4546
6. L. Sun, G. Wu, and J.K. Willson Expression of transforming growth factor β type II receptor leads to reduced malignancy in human breast cancer MCF-7 cells J Biol Chem 269 1994 26449 26455
7. Y. Guo, S.C. Jacobs, and N. Kyprianou Down-regulation of protein and mRNA expression for transforming growth factor-beta (TGF-beta 1) type I and type II receptors in human prostate cancer Int J Cancer 71 1997 573 579
8. K. Park, S.J. Kim, and Y.J. Bang Genetic changes in the transforming growth factor β type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth-inhibition by TGF-β Proc Natl Acad Sci USA 91 1994 8772 8776
9. S. Markowitz, J. Wang, and L. Myeroff Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability Science 268 1995 1336 1338
10. L.L. Myeroff, R. Parsons, and S.J. Kim A transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability Cancer Res 55 1995 5545 5547
11. M.E. Kadin, M.W. Cavaille-Coll, R. Gertz, J. Massague, S. Cheifetz, and D. George Loss of receptors for transforming growth factor beta in human T-cell malignancies Proc Natl Acad Sci USA 91 1994 6002 6006
12. L. Garrigue-Antar, T. Munoz-Antonia, S.J. Antonia, J. Gesmonde, V.F. Vellucci, and M. Reiss Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells Cancer Res 55 1995 3982 3987
13. J.C. Wang, A. Novetsky, C. Chen, and A.D. Novetsky Plasma matrix metalloproteinase and tissue inhibitor of metalloproteinase in patients with agnogenic myeloid metaplasia or idiopathic primary myelofibrosis Br J Haematol 119 2002 709 712
14. J.C. Wang, and G. Hashmi Elevated thrombopoietin levels in patients with myelofibrosis may not be due to enhanced production of thrombopoietin by bone marrow Leuk Res 27 2003 121 123
15. J.C. Wang, K. Hemavathy, and W. Charles Osteosclerosis in idiopathic myelofibrosis is related to the overproduction of osteoprotegerin (OPG) Exp Hematol 32 2004 905 910
16. J. Li, A.J. Bench, B.J. Huntly, and A.R. Green Mutation and methylation analysis of the transforming growth factor beta receptor II gene in polycythaemia vera Br J Haematol 115 2001 872 880
17. H.M. Rooke, M.R. Vitas, P.S. Crosier, and K.E. Crosier The TGF-beta type II receptor in chronic myeloid leukemia: analysis of microsatellite regions and gene expression Leukemia 13 1999 535 541
18. N. Fortunel, J. Hatzfeld, and S. Kisselev Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-beta type II receptor in a short-term in vitro assay Stem Cells 18 2000 102 111
19. E.R. Seijo, H. Song, and M.A. Lynch Identification of genetic alterations in the TGF beta type II receptor gene promoter Mutat Res 483 2001 19 26
20. S. Hougaard, P. Norgaard, N. Abrahamsen, H.L. Moses, M. Spang-Thomsen, and H. Skovgaard Poulsen Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines Br J Cancer 79 1999 1005 1011
21. J. Akahira, Y. Sugihashi, K. Ito, H. Niikura, K. Okamura, and N. Yaegashi Promoter methylation status and expression of TMS1 gene in human epithelial ovarian cancer Cancer Sci 95 2004 40 43
22. E. Dulaimi, I. Ibanez de Caceres, and R.G. Uzzo Promoter hypermethylation profile of kidney cancer Clin Cancer Res 10 2004 3972 3979
23. A. Goel, C.N. Arnold, and D. Niedzwiecki Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers Cancer Res 64 2004 3014 3021
24. R. Singal, L. Ferdinand, I.M. Reis, and J.J. Schlesselman Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease Oncol Rep 12 2004 631 637
25. H.T. Zhang, X.F. Chen, and M.H. Wang Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer Clin Cancer Res 10 2004 2359 2367
26. R.R. de Jonge, L. Garrigue-Antar, V.F. Vellucci, and M. Reiss Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells Oncol Res 9 1997 89 98
27. + cells in patients with agnogenic myeloid metaplasia Blood 104 2004 4218 ASH Meeting Abstracts
28. H. Osada, Y. Tatematsu, and A. Masuda Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines Cancer Res 61 2001 8331 8339
29. S. Zhao, K. Venkatasubbarao, S. Li, and J.W. Freeman Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta type II receptor expression in human pancreatic cancer cells Cancer Res 63 2003 2624 2630
30. K. Venkatasubbarao, S. Ammanamanchi, M.G. Brattain, D. Mimari, and J.W. Freeman Reversion of transcriptional repression of Sp1 by 5 aza-2′ deoxycytidine restores TGF-beta type II receptor expression in the pancreatic cancer cell line MIA PaCa-2 Cancer Res 61 2001 6239 6247
31. Y. Kim, V. Ratziu, and S.G. Choi Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter-binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury J Biol Chem 273 1998 33750 33758
32. S.H. Park, S.R. Lee, and B.C. Kim Transcriptional regulation of the transforming growth factor beta type II receptor gene by histone acetyltransferase and deacetylase is mediated by NF-Y in human breast cancer cells J Biol Chem 277 2002 5168 5174
33. K.D. Fralix, S. Zhao, K. Venkatasubbarao, and J.W. Freeman Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line. UK Pan-1 J Cell Physiol 194 2003 88 99
34. J.L. Kopp, P.J. Wilder, and M. Desler Unique and selective effects of five Ets family members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the promoter of the type II transforming growth factor-beta receptor gene J Biol Chem 279 2004 19407 19420